It was previously found that NAT10 promotes metastasis in HCC through epithelial-mesenchymal transition (EMT) [62], and contributes to doxorubicin chemoresistance in HCC by regulating chemotherapy-induced EMT with unknown mechanism [43]. The gene discussed is NAT10; the disease is hepatocellular carcinoma.